XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue
 12 Months Ended
Dec. 31, 2022
Revenue  
Revenue

2.Revenue

The Company initiated sales in the United States of CIMERLI on October 3, 2022. The Company’s net revenue was as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 

(in thousands)

    

2022

​

2021

​

2020

Products

​

​

​

​

​

​

​

​

​

UDENYCA

​

$

203,814

​

$

326,509

​

$

475,824

CIMERLI

​

​

6,946

​

​

—

​

​

—

Total net product revenue

​

​

210,760

​

​

326,509

​

​

475,824

Other

​

 

282

​

 

42

​

 

—

Total net revenue

​

$

211,042

​

$

326,551

​

$

475,824

​

Revenue by significant Customer was as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31,

 

​

​

2022

​

​

2021

 

​

2020

 

McKesson Corporation

​

38

%

​

39

%

​

38

%

AmeriSource-Bergen Corporation

​

44

%

​

39

%

​

37

%

Cardinal Health, Inc.

​

17

%

​

20

%

​

23

%

​

Product Sales Discounts and Allowances

The activities and ending reserve balances for each significant category of discounts and allowances, which constitute variable consideration, were as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 2022

​

    

Chargebacks

    

​

​

    

Other Fees,

    

​

​

​

​

and Discounts

​

​

​

​

Co-pay

​

​

​

​

​

for Prompt

​

​

​

​

Assistance

​

​

​

(in thousands)

​

Payment

​

Rebates

​

and Returns

​

Total

Balances at December 31, 2021

​

$

29,665

​

$

54,004

​

$

26,054

​

$

109,723

Provision related to sales made in:

​

 

​

​

​

​

​

​

​

​

​

​

Current period

​

​

436,865

​

​

68,399

​

​

73,435

​

​

578,699

Prior period

​

​

(2,090)

​

​

(1,050)

​

​

32

​

​

(3,108)

Payments and customer credits issued

​

 

(421,763)

​

​

(82,640)

​

​

(80,408)

​

​

(584,811)

Balances at December 31, 2022

​

$

42,677

​

$

38,713

​

$

19,113

​

$

100,503

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 2021

​

    

Chargebacks

    

​

​

    

Other Fees,

    

​

​

​

​

and Discounts

​

​

​

​

Co-pay

​

​

​

​

​

for Prompt

​

​

​

​

Assistance

​

​

​

(in thousands)

​

Payment

​

Rebates

​

and Returns

​

Total

Balances at December 31, 2020

​

$

40,580

​

$

54,058

​

$

28,760

​

$

123,398

Provision related to sales made in:

​

​

​

​

​

​

​

​

​

​

​

​

Current period

​

 

470,791

​

​

113,705

​

​

94,703

​

​

679,199

Prior period

​

​

(2,876)

​

​

(4,976)

​

​

(3,555)

​

​

(11,407)

Payments and customer credits issued

​

 

(478,830)

​

 

(108,783)

​

 

(93,854)

​

 

(681,467)

Balances at December 31, 2021

​

$

29,665

​

$

54,004

​

$

26,054

​

$

109,723

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended December 31, 2020

Balances at December 31, 2019

​

$

35,159

​

$

27,494

​

$

24,494

​

$

87,147

Provision related to sales made in:

​

​

​

​

​

​

​

​

​

​

​

​

Current period

​

 

462,328

​

​

115,864

​

​

114,372

​

​

692,564

Prior period

​

​

(1,336)

​

​

(3,438)

​

​

(6,288)

​

​

(11,062)

Payments and customer credits issued

​

 

(455,571)

​

 

(85,862)

​

 

(103,818)

​

 

(645,251)

Balances at December 31, 2020

​

$

40,580

​

$

54,058

​

$

28,760

​

$

123,398

​

Chargebacks and discounts for prompt payment are recorded as a reduction in trade receivables, and the remaining reserve balances are classified as current liabilities and other liabilities, non-current in the accompanying consolidated balance sheets.